MiND Biosciences continues to advance its research into molecular biomarkers associated with Motor Neurone Disease (MND). By integrating epigenetic, epitranscriptomic and transcriptomic analysis, the platform is identifying molecular signatures that may improve biological understanding and support the development of future blood-based diagnostic approaches.
Advancing biomarker discovery in Motor Neurone Disease
